RadNet (NASDAQ:RDNT) Shares Gap Up – What’s Next?

RadNet, Inc. (NASDAQ:RDNT) shares gapped up before the market opened on Monday . The stock had previously closed at $58.19, but opened at $63.45. RadNet shares last traded at $59.81, with a volume of 216,446 shares traded.

RadNet News Roundup

Here are the key news stories impacting RadNet this week:

• Positive Sentiment: RadNet reported record first-quarter revenue of $575.63 million, up 22.1% year over year and above analyst expectations, showing continued demand for its imaging services. Press Release
• Positive Sentiment: The company raised its 2026 imaging center guidance for revenue, adjusted EBITDA and free cash flow, signaling management is more confident about the year ahead. Guidance Update
• Neutral Sentiment: Quarterly EPS came in at -$0.28, missing the consensus estimate of $0.19, so profitability remains a concern despite the revenue beat. Earnings Transcript
• Neutral Sentiment: Investor focus also remains on the earnings call details and management commentary, which may help explain how RadNet plans to convert strong revenue growth into better margins over time. Earnings Call Transcript
• Negative Sentiment: The earnings miss and continued negative net margin highlight that RadNet is still not consistently translating sales growth into bottom-line earnings, which could limit upside. Transcript

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on RDNT shares. Jefferies Financial Group restated a “buy” rating and set a $91.00 target price on shares of RadNet in a report on Tuesday, March 3rd. Barclays reduced their target price on RadNet from $86.00 to $70.00 and set an “overweight” rating on the stock in a report on Tuesday, April 21st. Two investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.14.

RadNet Stock Performance

The company has a debt-to-equity ratio of 0.79, a current ratio of 1.17 and a quick ratio of 1.76. The company has a market cap of $4.38 billion, a price-to-earnings ratio of -311.09 and a beta of 1.43. The stock has a 50-day moving average price of $59.43 and a 200 day moving average price of $69.32.

RadNet (NASDAQ:RDNT) last released its quarterly earnings data on Monday, May 11th. The medical research company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.14). RadNet had a negative net margin of 0.66% and a positive return on equity of 2.77%. The business had revenue of $575.63 million for the quarter, compared to the consensus estimate of $557.93 million. During the same quarter last year, the firm earned ($0.50) EPS. The company’s revenue for the quarter was up 22.1% on a year-over-year basis. As a group, analysts anticipate that RadNet, Inc. will post 0.62 EPS for the current fiscal year.

Insider Buying and Selling at RadNet

In other news, insider Alma Gregory Sorensen sold 15,000 shares of RadNet stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $62.15, for a total transaction of $932,250.00. Following the transaction, the insider owned 1,208,923 shares in the company, valued at $75,134,564.45. The trade was a 1.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 5.60% of the stock is owned by company insiders.

Hedge Funds Weigh In On RadNet

Several institutional investors have recently modified their holdings of the business. PNC Financial Services Group Inc. lifted its holdings in shares of RadNet by 2.9% during the 1st quarter. PNC Financial Services Group Inc. now owns 7,392 shares of the medical research company’s stock valued at $413,000 after purchasing an additional 207 shares in the last quarter. Van Berkom & Associates Inc. lifted its holdings in shares of RadNet by 24.9% during the 1st quarter. Van Berkom & Associates Inc. now owns 1,028,586 shares of the medical research company’s stock valued at $57,488,000 after purchasing an additional 204,858 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of RadNet by 1.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,379,003 shares of the medical research company’s stock valued at $77,074,000 after purchasing an additional 19,188 shares in the last quarter. Parallel Advisors LLC lifted its holdings in shares of RadNet by 80.0% during the 1st quarter. Parallel Advisors LLC now owns 1,114 shares of the medical research company’s stock valued at $62,000 after purchasing an additional 495 shares in the last quarter. Finally, SEB Asset Management AB bought a new position in shares of RadNet during the 1st quarter valued at about $4,287,000. Institutional investors own 77.90% of the company’s stock.

RadNet Company Profile

RadNet, Inc is a leading independent provider of outpatient diagnostic imaging services in the United States. Through a nationwide network of fixed-site imaging centers and affiliated joint-venture locations, the company delivers a comprehensive suite of radiology services including MRI, CT, PET/CT, ultrasound, X-ray, mammography, bone densitometry, nuclear medicine and interventional radiology procedures. RadNet also offers teleradiology and imaging management solutions to physician practices, hospitals and healthcare systems.

Founded in 1981 and headquartered in Los Angeles, RadNet has expanded its footprint organically and through strategic acquisitions.